Category Oncology
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Perspectives on Proteomics and Cancer
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1020Published: October 2020Expires: 9/30/2022Sources: Oncology TimesDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Perspectives on Proteomics and Cancer ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN1020Published: October 2020Expires: 9/30/2022Sources: Oncology TimesDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Biomarker-Driven Cancer Care Is Not Reaching All Americans
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0920Published: September 2020Expires: 9/1/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Biomarkers , Cancer Therapies -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Biomarker-Driven Cancer Care Is Not Reaching All Americans ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN0920Published: September 2020Expires: 9/1/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Biomarkers , Cancer Therapies -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Cancer Immunotherapy Paves the Way for Better Understanding of COVID-19
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0820Published: August 2020Expires: 7/31/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: COVID-19 , Cancer Immunotherapies -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Cancer Immunotherapy Paves the Way for Better Understanding of COVID-19 ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN0820Published: August 2020Expires: 7/31/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: COVID-19 , Cancer Immunotherapies -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Androgen Deprivation Therapy Could Protect Men Against COVID-19
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0720Published: July 2020Expires: 7/31/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Androgen Deprivation Therapy , COVID-19 -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Androgen Deprivation Therapy Could Protect Men Against COVID-19 ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN0720Published: July 2020Expires: 7/31/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Androgen Deprivation Therapy , COVID-19 -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Genomic Sequencing Initiative Advances Angiosarcoma Research
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0620Published: June 2020Expires: 6/1/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Angiosarcoma , Genomics -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Genomic Sequencing Initiative Advances Angiosarcoma Research ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN0620Published: June 2020Expires: 6/1/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: Angiosarcoma , Genomics